Merkel cell carcinoma (MCC) is a rare skin cancer that is associated with Merkel cell
polyomavirus infection in most cases. Incidence rates of MCC have increased in past …

Non-melanoma skin cancers (NMSCs) include basal cell carcinoma (BCC), squamous cell
carcinoma (SCC) and Merkel cell carcinoma (MCC). These neoplasms are highly diverse in …

Background Merkel cell carcinoma is a rare, aggressive skin cancer with poor prognosis in
patients with advanced disease. Current standard care uses various cytotoxic chemotherapy …

Background Merkel-cell carcinoma is an aggressive skin cancer that is linked to exposure to
ultraviolet light and the Merkel-cell polyomavirus (MCPyV). Advanced Merkel-cell carcinoma …

This selection from the NCCN Guidelines for Merkel Cell Carcinoma (MCC) focuses on
areas impacted by recently emerging data, including sections describing MCC risk factors …

Cytotoxic chemotherapy is commonly used to treat advanced Merkel cell carcinoma (MCC).
However, its efficacy in distant metastatic MCC patients is unclear, in part because most …

Purpose: Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous malignancy, which
has demonstrated sensitivity to immune checkpoint inhibitor therapy. Here, we perform the …

Merkel cell carcinoma (MCC) is a rare tumour of the skin of neuro-endocrine origin probably
developing from neuronal mechanoreceptors. A collaborative group of multidisciplinary …

Purpose Merkel cell carcinoma (MCC) is an uncommon cutaneous malignancy. Most reports
consist of single-institution experiences of fewer than 30 patients. The natural history of MCC …

Background: Merkel cell carcinoma (MCC) has a high risk of recurrence after initial surgical
therapy. Adjuvant radiation therapy (RT) and chemotherapy may be used to reduce the risk …